[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.201.14. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,799
Citations 0
In This Issue of JAMA Internal Medicine
February 2014

Highlights

JAMA Intern Med. 2014;174(2):173-175. doi:10.1001/jamainternmed.2013.10635

Adherence to cardioprotective medications in the year after acute coronary syndrome (ACS) hospitalization is poor. Ho and coauthors conducted a randomized clinical trial of 253 patients to test a multifaceted intervention against usual care. In the intervention group, 89.3% of patients were adherent compared with 73.9% in the usual care group (P = .003). They found no statistically significant differences in the proportion of patients who achieved blood pressure and low-density lipoprotein cholesterol goals or in clinical events. In an Editor’s Note, Redberg urges caution in implementing costly interventions before significant improvement in patient outcomes is demonstrated.

Editor’s Note

×